drug · small molecule
CB-0311
Phase 3updated 3mo agoby Cosmo Pharmaceuticals NV🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 7- druglatanoprost SR1 co-mentions · 1 sources
- drugLATANOPROST1 co-mentions · 1 sources
- companyGlenmark Pharmaceuticals Ltd1 co-mentions · 1 sources
- tagDermatology1 co-mentions · 1 sources
- drugclascoterone1 co-mentions · 1 sources
- drugXalatan1 co-mentions · 1 sources
- drug(clascoterone + latanoprost)1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for acne and 1 investigational indication.
targets
Androgen receptor
all catalysts(0)
nothing on the calendar yet
Trials studying CB-0311
- phase3A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
- phase31% Clascoterone Cream for the Treatment Acne Vulgaris
- phase4A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
- phase4A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne
- phase3A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
- phase4A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne
- phase4A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne
- phase3Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that